The outdoor clothing retailer’s largest shareholder had called for the sale of wholesale footwear subsidiary Oboz.
The Canadian exchange wants to become a go-to destination for resources companies and investors.
Oscillator maker’s shares are up nearly 40% in two days.
The cancer diagnostics company, after a trading halt this morning, says it should get better prices for its tests in the US if Medicare funding can be restored.
Commerce Act competition review process raises questions about airport information disclosure regime.
Prominent leaders surveyed for Tuanz’s annual Digital Priorities Report believe the Govt is missing in action.
Lorraine Witten had been on the board since 2017 and chair since 2022, but her departure forms part of a ‘board refresh’.
The cancer diagnostics company’s share price dives after finally losing reimbursement of 60% of its US revenue.
Global case sales now forecast to fall 12% on last year.
An increased offer by Singaporean majority owner CDL is still a 'material discount' to the assets of the hotel group, but shareholders can expect a 'material' drop in the trading price and dividends to dry up if they don't accept.